Self-Sampling for HPV-DNA
Clinical data shows that vaginal self-sampling with HPV-DNA test is a promising screening method for cervical cancer particularly in emerging countries with limited medical resources. Most women participating in self-assessment programs agreed that this method provides them with a sense of control over their own screening. This results in a feeling of empowerment and the ability to avoid the embarrassment, anxiety or fear caused by pelvic examination.
Self-sampling method detects high-risk HPV infections with similar sensitivity as a cervical Pap smear taken by a gynecologist. Self-sampling for HPV-DNA testing, complement current screening programs by increasing population coverage in settings that do not have easy access to comprehensive cytology-based screening, or where socio-cultural barriers increase the non-attending women in organized screening cervical cancer programs.
"Self-sampling with XytoTest is widely acceptable among women in rural and sub-urban areas through organized screening campaigns, and probably the only opportunity that many women in developing countries might have to know their condition on regards to Cervical Cancer. HPV-DNA test increases the sensitivity for the early detection of high-risk HPV and pre-cancerous lesions."